Clinical trial
New Strategies to Assess Anal Cancer Risk In Women
NCT02873741 is registered in ClinicalTrials.gov with Emory University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- New Strategies to Assess Anal Cancer Risk In Women
- Lead sponsor
- Emory University
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2016
- Completion date
- February 27, 2017
- Enrollment
- 143 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
human immunodeficiency virus (hiv), human papillomavirus (hpv)